Description
PART I: FOUNDATIONS OF ASSESSMENT 1 The Expanding Role of Neuropsychology, Michelle M. Braun, Michael W. Parsons 2 Cultural and Linguistic Factors in Assessment, Daryl Fujii 3 Pediatric Assessment, Elisabeth Vogt, Amy Heffelfinger 4 Performance and Symptom Validity Testing, Kyle Brauer Boone 5 Assessment of Emotion, Mood, and Affect, Hillary Abel, Dawn Bowers 6 Neurobehavioral Examination, Ekaterina Keifer, Jennifer W. Hartzell, William T. McCuddy, Katharine E. Lindberg & Marc W. Haut 7 Medications and Laboratory Tests, Alexander D. Rae Grant 8 Brain Imaging & EEG, Michael W. Parsons, Catherine Leveroni PART II: NEUROPSYCHOLOGICAL SYNDROMES 9 Disorders of Attention, Ronald A. Cohen, Melissa Jenkins & Robert Paul 10 Amnesic Syndromes, Margaret G. O'Connor, Elizabeth Race 11Aphasia, David S. Sabsevitz & Sara B. Pillay 12 Visuospatial, Visuoperceptual, and Visuoconstructional Disorders, Russell M. Bauer 13 Executive Function Disorders, Darlene Floden, Katherine Reiter PART III: NEUROLOGICAL DISORDERS 14 Cerebral Vascular Disease, David Nyenhuis, Jaclyn Reckow 15 Mild Cognitive Impairment and Dementia, Crystal G. Quinn, Laura A. Rabin, & Andrew J. Saykin 16 Traumatic Brain Injury and Persistent Postconcussive Syndrome, Michael A. McCrea, Karen A. Martinez, Julie K. Janacek, Benjamin Brett, & Lindsay D. Nelson 17 Epilepsy, Sara J. Swanson, Jessica S. Chapin, & Julie K. Janacek 18 Movement Disorders and Deep Brain Stimulation, Alexander I. Troester & Alexandra Novak 19 Multiple Sclerosis and Demyelinating Disorders, Peter A. Arnett & Lauren B. Strober 20 Oncology, Benjamin D. Eschler, Jeffrey S. Wefel, & Mariana E. Bradshaw 21 Autoimmune and Infectious Disorders, Christina D. Kay PART IV: NEUROPSYCHIATRIC AND NEUROBEHAVIORAL SYNDROMES 22 Intellectual Disability, Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Specific Learning Disorders Across the Lifespan, Lisa L. Conant & Lauren E. Miller 23 Substance Use and Impulse Control Disorders, Grace J. Goodwin, Jessica J. Woodyatt, Christine E. Salva, & Daniel N. Allen 24 Late-life Depression, Rishi K. Balla, Alex R. Terpstra, & Meryl A. Butters 25 Anxiety and Trauma-related Disorders, Danielle Shaked & Jennifer J. Vasterling 26 Schizophrenia, Robert M. Bilder 27 Somatic Symptom Disorders, Greg J. Lamberty
Michael W. Parsons, PhD, ABPP, is a clinical neuropsychologist in the Pappas Neuro-Oncology Center and Department of Psychiatry at Massachusetts General Hospital. His clinical and research activities focus on the cognitive and behavioral consequences of cancer, including brain tumors and non-central nervous system cancers. He is the author of numerous peer reviewed manuscripts and book chapters related to these issues and serves as the copresident of the neuro-oncology special interest group of the International Neuropsychological Society. Dr. Parsons is a diplomate of the American Board of Clinical Neuropsychology and the American Board of Professional Psychology. Michelle M. Braun, PhD, earned her Master of Science and PhD in clinical psychology with a minor in neuroscience from the University of Wisconsin-Milwaukee. Dr. Braun has worked for 15 years as a clinical neuropsychologist in departments of neurology, neurosurgery, and psychiatry in hospitals and academia. She serves as an examiner for the American Board of Clinical Neuropsychology, and is a previous board member of the board of directors of the American Academy of Clinical Neuropsychology, where she chaired the Practice and Public Policy Committee. She is also a previous member of the board of directors of the Wisconsin Psychological Association.